MEG8 and liver cancer: Analysis of clinical samples revealed that the expression levels of SNHG1, SNHG3‐7, SNHG16, SNHG20, and MEG8 (Maternally expressed 8, also known as SNHG23) are associated with clinical indicators of liver cancer patients.